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INTRODUCTION
Lung cancer is the most common cause of cancer-related death in Canada (Hirsch et al., 2017). 
One of the most promising treatments of lung cancer is immunotherapy, yet, it is difficult to 
determine which patients would benefit from this treatment. Furthermore, immunotherapy can 
result in various side effects in patients, sometimes without effective treatment. High tumour 
mutational burden (TMB)  is a promising biomarker for immunotherapy success in lung 
squamous cell carcinoma patients (Dammak et al., 2020). Unfortunately, a test for TMB is very 
time-consuming and costly making it difficult to implement in a clinical setting. 
Previous studies have shown that genetic information is encoded into the morphology of lung 
cancer (Dammak et al., 2020); thus, with image analysis software and computational pathology, 
it is theoretically possible to develop an algorithm to predict  tumour mutational burden from a 
whole slide image depicting the morphology of tumour. Yet, this algorithm would require large 
numbers of  annotations of tumour to feed for learning data. These annotations would typically 
be completed by pathologists, but identification of tumour cells can theoretically be performed 
by non-pathologists with training on the image recognition task. Digital image analysis tools can 
then be applied to the annotated images in order to quantify the tumour cells. QuPath is one of 
such computational pathology tools that can calculate tumour density on manual annotations 
(Bankhead et al., 2017).
In a previous study, we determined that there was minimal difference in accuracy of tumour 
annotations between a trained non-pathologist and a pathologist when identifying lung 
adenocarcinoma. Yet, to date, no studies have compared the accuracy of tumour annotations 
between trained non-pathologists and pathologists in squamous cell carcinoma of the lung. It 
was hypothesized that non-pathologist reviewers with brief training in lung histology could learn 
how to reliably identify and contour tumor cells of lung squamous cell carcinoma with similar 





Figure 2: Outline of Methodology Used To Test Hypothesis
Figure 4. (A) Surface Areas of annotated tumour by non-pathologist and pathologist on 15 different 1260umx1260um squares from 
different squamous cell carcinoma digital slides obtained from TCGA; (B) Mean surface Area (+/- SD) of tumour annotated by a 
non-pathologist and a pathologist on fifteen different lung squamous cell carcinoma cases from The Cancer Genome Atlas (TCGA) 
after dividing each slide into dimensions of 1260 x 1260 um boxes on QuPath. A significant difference is marked by * and represents a 
p value of <0.05.
Non-pathologists can visually identify and create robust contours of tumour areas in lung 
squamous cell carcinoma slides with a high degree of accuracy, minimal training and 
supervision. These results support the idea that trained non-pathologists can annotate these 
lung tumors with similar accuracy to a pathologist and supports our previous study with 
similar results on lung squamous cell carcinoma annotations.
These annotated image files will serve as the basis for developing machine learning algorithms 
such as to calculate tumour mutational burden for immunotherapy success rate and 
estimation of tumor cell density to assess outcome of patient. 
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In this subset analysis of 15 representative 1260 x 1260 um squares there was good agreement 
between the non-pathologist and pathologist reviewer. In this subset analysis  87% of the 
squares were revised, however, this corresponded to a small absolute change in the reviewed 
surface area. The average absolute percent difference in surface area of annotated tumours 
between a pathologist and non-pathologist reviewers between the three cases was 4.7% 
(N=15). Additionally, no significant differences were revealed between the surface areas 
annotated by the non-pathologist and ones revised by the pathologist.
This contouring was then applied to a larger dataset to support downstream machine learning 
algorithms.
  SUMMARY OF RESULTS
Figure 5. High magnification images of cases contoured by a non-pathologist where (A) additional small areas of tumour (black 





Figure 1. High magnification images of histological slides of tumours with high tumour mutational burden (A) and low tumour 
mutational burden (B).
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